日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Cajanonic acid A derivative XJ-60 improves liver fibrosis in mice with non-alcoholic fatty liver disease by inhibiting the SP1/TGF-β/Smad3 signaling axis]

[卡加宁酸A衍生物XJ-60通过抑制SP1/TGF-β/Smad3信号通路改善非酒精性脂肪肝小鼠的肝纤维化]

Geng, Zhaodie; Hu, Li; Dai, Yunli; Luo, Ronggang; Xu, Tao; Liao, Xuyang; Yuan, Zhiping; Wang, Jianta; Xiao, Ying

Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease

发现用于治疗阿尔茨海默病的新型丁酰胆碱酯酶抑制剂

Sang, Zhipei; Huang, Shuheng; Tan, Wanying; Ban, Yujuan; Wang, Keren; Fan, Yufan; Chen, Hongsong; Zhang, Qiyao; Liang, Chanchan; Mi, Jing; Gao, Yunqi; Zhang, Ya; Liu, Wenmin; Wang, Jianta; Dong, Wu; Tan, Zhenghuai; Tang, Lei; Luo, Haibin

Development of Novel 3‑Phenylpropanamide Derivatives as BChE Inhibitors for the Treatment of Alzheimer's Disease

开发新型3-苯基丙酰胺衍生物作为丁酰胆碱酯酶抑制剂用于治疗阿尔茨海默病

Wu, Haibo; Huang, Na; Wang, Keren; Mi, Jing; Liu, Zhengwei; Wang, Jianta; Sang, Zhipei; Tan, Zhenghuai

Amorfrutin A ameliorates cerebral ischemia/reperfsion injury in vivo and in vitro via modulating Nrf2/HO-1 signaling pathway.

阿莫弗林A通过调节Nrf2/HO-1信号通路,在体内和体外改善脑缺血/再灌注损伤

Yang Youxi, Shi Liying, Xu Xiaoting, Luo Bilan, Cui Xing, Tang Lei, Wang Jianta

Design, synthesis and evaluation of 2, 6, 8-substituted Imidazopyridine derivatives as potent PI3Kα inhibitors

设计、合成和评价2,6,8-取代的咪唑并吡啶衍生物作为强效PI3Kα抑制剂

Chen, Rui; Wang, Zhongyuan; Sima, Lijie; Cheng, Hu; Luo, Bilan; Wang, Jianta; Guo, Bing; Mao, Shunyi; Zhou, Zhixu; Peng, Jingang; Tang, Lei; Liu, Xinfu; Liao, Weike

Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma

对PPARG作为致癌驱动因子的综合研究和实验验证:对肝细胞癌预后评估和治疗靶向的意义

Ran, Yunsheng; Hu, Chujiao; Wan, Junzhao; Kang, Qian; Zhou, Ruixian; Liu, Ping; Ma, Dan; Wang, Jianta; Tang, Lei